Search

everythinglearnresearchcommunity

for

Search:↓

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

Antizyme reduces tumor growth and normalizes skin cell development affected by MEK.

GnRH treatment can reduce breast cancer cell invasion.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Sentinel lymph node biopsy is recommended for all types of desmoplastic melanoma due to higher rates of nodal metastasis.

Sentinel lymph node biopsy is recommended for all types of desmoplastic melanoma due to higher rates of nodal metastasis.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Immunotherapy can help treat severe alopecia areata.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Microneedles can precisely deliver cancer treatments with fewer side effects.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Melanoma research shifted focus to immunotherapy drugs after 2010, increasing their study and citations.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.